docetaxel anhydrous has been researched along with amg531 in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (amg531) | Trials (amg531) | Recent Studies (post-2010) (amg531) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 713 | 94 | 607 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | amg531 (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 8.27 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.6605 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chumsri, S; Zimrin, A | 1 |
1 other study(ies) available for docetaxel anhydrous and amg531
| Article | Year |
|---|---|
Profound thrombocytopenia in patient with ITP treated with chemotherapy for breast cancer and subsequent remission after romiplostim.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzoates; Bone Marrow; Breast Neoplasms; Cyclophosphamide; Docetaxel; Drug Resistance; Female; Humans; Hydrazines; Mastectomy, Segmental; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Estrogen; Receptors, Fc; Recombinant Fusion Proteins; Remission Induction; Splenectomy; Taxoids; Thrombocytopenia; Thrombopoietin | 2013 |